Health Technology Assessment (Jun 2009)

Trastuzumab for the treatment of primary HER2-positive breast cancer in HER2-positive women: a single technology appraisal

  • S Ward,
  • H Pilgrim,
  • D Hind

DOI
https://doi.org/10.3310/hta13suppl1/01
Journal volume & issue
Vol. 13, no. Suppl 1

Abstract

Read online

No abstracts available.